IL12B and psoriasis: In psoriasis, IL12B promotes pathogenic IL-23 signaling that drives Th17-mediated skin inflammation, whereas in AD, IL12B variation influences IL-12–dependent neuroinflammatory pathways and modulates susceptibility to cognitive decline.